The effectiveness of esomeprazole 40 mg in patients with persistent symptoms of gastro-oesophageal reflux disease following treatment with a full dose proton pump inhibitor

BACKGROUND: Some patients with gastro-oesophageal reflux disease (GORD) remain symptomatic despite proton pump inhibitor (PPI) treatment. There is a need to determine the most appropriate management of these patients. AIMS: To assess the effectiveness of esomeprazole 40 mg in GORD symptoms persistin...

Descripción completa

Detalles Bibliográficos
Autores principales: Jones, R, Patrikios, T
Formato: Texto
Lenguaje:English
Publicado: Blackwell Publishing Ltd 2008
Materias:
Original Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2680259/
https://www.ncbi.nlm.nih.gov/pubmed/19166433
http://dx.doi.org/10.1111/j.1742-1241.2008.01923.x

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2680259/
https://www.ncbi.nlm.nih.gov/pubmed/19166433
http://dx.doi.org/10.1111/j.1742-1241.2008.01923.x

Ejemplares similares